↓ Skip to main content

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

Overview of attention for article published in Frontiers in Cellular and Infection Microbiology, March 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
11 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
62 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata
Published in
Frontiers in Cellular and Infection Microbiology, March 2021
DOI 10.3389/fcimb.2021.642358
Pubmed ID
Authors

Ahmed Gamal, Sherman Chu, Thomas S. McCormick, Katyna Borroto-Esoda, David Angulo, Mahmoud A. Ghannoum

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 62 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 15%
Student > Ph. D. Student 6 10%
Student > Bachelor 6 10%
Researcher 4 6%
Student > Doctoral Student 3 5%
Other 10 16%
Unknown 24 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 19%
Immunology and Microbiology 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Medicine and Dentistry 5 8%
Agricultural and Biological Sciences 2 3%
Other 6 10%
Unknown 26 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2022.
All research outputs
#5,426,086
of 25,443,857 outputs
Outputs from Frontiers in Cellular and Infection Microbiology
#1,150
of 8,110 outputs
Outputs of similar age
#130,099
of 452,317 outputs
Outputs of similar age from Frontiers in Cellular and Infection Microbiology
#78
of 390 outputs
Altmetric has tracked 25,443,857 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,110 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,317 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 390 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.